|
|
|
|
Ward R. Richter, DVM. MS, ACVP Chief Scientific Officer & Vice President
Dr. Ward R. Richter joined DRUQUEST on April 1 of 2002. He will provide consulting services in toxicology, pathology and related disciplines. He will be available to design preclinical testing strategies leading to INDs and NDAs, to assist in writing INDs or NDAs and to provide histopathology support and pathology peer reviews. Dr Richter also will provide consultation on data management and information technology related to preclinical safety testing.
Dr. Richter has many years of experience managing toxicology research and testing in an academic department, in a pharmaceutical company, in a chemical company and in three contract research organizations. He served on the first Scientific Advisory Board for NCTR and on ad hoc committees for NCI, NIEHS, and HEW, thus giving him an insight into the scientific and regulatory requirements of government agencies. He has managed research and testing programs for biopharmaceutical companies and government agencies leading to IND and NDA submissions and has managed research for regulatory submissions for the EPA.
Recently (1998-2002) he served as Director of the Safety Assessment Department for Southern Research Institute. The Department included the disciplines of Toxicology, Pathology, ADME/PK and Bioanalytical Chemistry. In addition to managing the department he served as the department’s primary resource for the design of registration strategies for Southern’s many clients. This included the design of studies and registration packages for small molecules, large molecules, gene vectors, vaccines and cellular products.
Prior to joining Southern Research Institute, he served as Vice President of Research and Principal Scientist for Huntingdon Life Sciences in New Jersey, Vice President & Scientific Director for Pharmaco-LSR in the US and World-Wide Director of Pathology for Pharmaco-LSR, all at the same laboratory under two different owners. At the New Jersey facility, he was responsible for a staff that varied between 250 and 400 in departments of Toxicology, Pathology, Chemistry, PK/ADME and Information Technology. As Principal Scientist he served on the worldwide Corporate Scientific Guidance Committee and IT Planning Committee for the UK Corporation (Huntingdon) of 1700. During his tenure at this laboratory, he was responsible for consultation on regulatory strategies to large and small pharmaceutical companies, especially those developing biotechnology products, and to Japanese companies seeking to register drugs in the U.S or Europe.
Earlier in his career, Dr. Richter conducted research on mechanisms of toxicity at Abbott Laboratories (1963-1968) and then as Associate Professor to Professor of Pathology at the University of Chicago Pritzker School of Medicine(1968-1980), where he directed the training of numerous graduate students and residents. While at the University, he also served as the Director of the Carlson Animal Research Facility, and he frequently served as a consultant to industry and government agencies. As his career progressed, he served as Director of the Pathology Division for IRDC (1980-1985), a contract research laboratory directing a staff of 100 to 125. Subsequently he was Director of Reproductive Toxicology, Genetic Toxicology, Pathology and Laboratory Animal Medicine for Chevron and later as Coordinator of Pesticide Product Safety for Chevron (1985-1990). In 1991 he joined Bio/dynamics in New Jersey, later known as Pharmaco-LSR, and subsequently sold to Huntingdon.
Dr. Richter is also an expert in Information Technology, founding and later selling a software company. Recently he served on an advisory panel to the EPA for Electronic Commerce. |
Contact
info@druquest.com for additional
information
|
